Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Catalysis SL
Jiangsu Cancer Institute & Hospital
Genexine, Inc.
AGO Study Group
Novartis
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.